Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
This study has been completed.
Study NCT00111553   Information provided by Infectious Disease Research Institute
First Received: May 23, 2005   Last Updated: February 13, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leishmaniasis, Cutaneous
Additional conditions recognized in this trial
Leishmaniasis
More general conditions related to this trial
Mastigophora Infections
Parasitic Diseases
Protozoan Infections
Sarcomastigophora Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
Leish-111f + MPL-SE vaccine
Sponsors listed in this trial
Infectious Disease Research Institute
Bill and Melinda Gates Foundation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services